HINFP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.979600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.228400E-01
Normal-vs-Stage2
6.418400E-01
Normal-vs-Stage3
1.501770E-01
Normal-vs-Stage4
4.858000E-01
Stage1-vs-Stage2
9.407800E-01
Stage1-vs-Stage3
8.559800E-02
Stage1-vs-Stage4
6.099800E-01
Stage2-vs-Stage3
8.548200E-02
Stage2-vs-Stage4
6.982200E-01
Stage3-vs-Stage4
3.020200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.950200E-01
Normal-vs-AfricanAmerican
9.952600E-01
Normal-vs-Asian
4.453000E-01
Caucasian-vs-AfricanAmerican
4.545800E-01
Caucasian-vs-Asian
5.025800E-01
AfricanAmerican-vs-Asian
3.755400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.240200E-01
Normal-vs-Female
5.526600E-01
Male-vs-Female
6.538200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.919200E-01
Normal-vs-Age(41-60Yrs)
9.831800E-01
Normal-vs-Age(61-80Yrs)
4.042200E-01
Normal-vs-Age(81-100Yrs)
4.576000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.257800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.273000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.038400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.104200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.810360E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.175800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.237200E-01
Normal-vs-Daily Drinker
8.562000E-01
Normal-vs-Weekly Drinker
1.149950E-01
Normal-vs-Occasional Drinker
4.652400E-01
Normal-vs-Social Drinker
5.450200E-01
Non Drinker-vs-Daily Drinker
6.782000E-01
Non Drinker-vs-Weekly Drinker
1.982980E-01
Non Drinker-vs-Occasional Drinker
8.140600E-01
Non Drinker-vs-Social Drinker
9.388000E-01
Daily Drinker-vs-Weekly Drinker
8.377900E-02
Daily Drinker-vs-Occasional Drinker
4.970600E-01
Daily Drinker-vs-Social Drinker
6.207600E-01
Weekly Drinker-vs-Occasional Drinker
2.111600E-01
Weekly Drinker-vs-Social Drinker
1.722820E-01
Occasional Drinker-vs-Social Drinker
8.595400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.480590E-01
Normal-vs-Grade 2
1.562350E-02
Normal-vs-Grade 3
3.633900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.355400E-01
Grade 1-vs-Grade 3
1.622990E-01
Grade 1-vs-Grade 4
1.480590E-01
Grade 2-vs-Grade 3
4.111600E-01
Grade 2-vs-Grade 4
1.562350E-02
Grade 3-vs-Grade 4
3.633900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.426400E-01
Normal-vs-NonDiabetic
7.448000E-01
Diabetic-vs-NonDiabetic
2.922300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.360800E-01
Normal-vs-NoPancreatitis
5.121200E-01
Pancreatitis-vs-NoPancreatitis
5.924900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.971000E-01
Normal-vs-N1
6.479800E-01
N0-vs-N1
9.635600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.628600E-01
Normal-vs-TP53-NonMutant
6.961200E-01
TP53-Mutant-vs-TP53-NonMutant
6.077300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
